RareCyte Garners New Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    228 9th Avenue North Seattle, WA 98109
  • Company Description
    RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. Our team of biologists and engineers is dedicated to building innovative technologies to better understand human health and disease.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    RareCyte plans to use the funds to complete the final stages of product development and initiate the platform’s commercial launch in the research oncology market.
  • M&A Terms
  • Venture Investor
    Telegraph Hill Partners
  • Venture Investor

By posting a comment, you agree to our terms and conditions.